Search Results - "Halperin, Jonathan"

Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week by Wang, Allen, Green, Jennifer B, Halperin, Jonathan L, Piccini, Sr, Jonathan P

“…Diabetes mellitus is one of the most common chronic medical conditions, and is a risk factor for the development of atrial fibrillation (AF). The presence of…”
Get full text

Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar by Giustino, Gennaro, Pinney, Sean P, Lala, Anuradha, Reddy, Vivek Y, Johnston-Cox, Hillary A, Mechanick, Jeffrey I, Halperin, Jonathan L, Fuster, Valentin

“…The cardiovascular system is affected broadly by severe acute respiratory syndrome coronavirus 2 infection. Both direct viral infection and indirect injury…”
Get full text

Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences by Hirsh, Benjamin J, Copeland-Halperin, Robert S, Halperin, Jonathan L

“…The association of atrial fibrillation (AF) with ischemic stroke has long been recognized; yet, the pathogenic mechanisms underlying this relationship are…”
Get full text

Deep learning for cardiovascular medicine: a practical primer by Krittanawong, Chayakrit, Johnson, Kipp W, Rosenson, Robert S, Wang, Zhen, Aydar, Mehmet, Baber, Usman, Min, James K, Tang, W H Wilson, Halperin, Jonathan L, Narayan, Sanjiv M

“…Deep learning (DL) is a branch of machine learning (ML) showing increasing promise in medicine, to assist in data classification, novel disease phenotyping and…”
Get full text

Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial by REDDY, Vivek Y, DOSHI, Shephal K, SIEVERT, Horst, BUCHBINDER, Maurice, NEUZIL, Petr, HUBER, Kenneth, HALPERIN, Jonathan L, HOLMES, David

“…The multicenter PROTECT AF study (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) was conducted to determine…”
Get full text

Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry by Mazurek, Michał, Huisman, Menno V, Rothman, Kenneth J, Paquette, Miney, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J, Halperin, Jonathan L, Ma, Chang Sheng, Zint, Kristina, Elsaesser, Amelie, Lu, Shihai, Lip, Gregory Y H

“…Introduction Although guideline-adherent antithrombotic therapy (ATT) for stroke prevention in atrial fibrillation (AF) is associated with lower mortality and…”
Get more information

Thoracic Aortic Aneurysm and Dissection by Goldfinger, Judith Z., MD, Halperin, Jonathan L., MD, Marin, Michael L., MD, Stewart, Allan S., MD, Eagle, Kim A., MD, Fuster, Valentin, MD, PhD

“…Abstract Aortic dissection is the most devastating complication of thoracic aortic disease. In the more than 250 years since thoracic aortic dissection was…”
Get full text

Thromboembolism in the Absence of Atrial Fibrillation by Smietana, Jeffrey, Plitt, Anna, Halperin, Jonathan L.

“…Atrial fibrillation (AF) is associated with thrombus formation in the left atrial appendage and systemic embolic events including ischemic stroke. Cardiogenic…”
Get full text

No conflict of interest in data monitoring by Halperin, Jonathan L

Get full text

Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management by Krittanawong, Chayakrit, Rogers, Albert J., Johnson, Kipp W., Wang, Zhen, Turakhia, Mintu P., Halperin, Jonathan L., Narayan, Sanjiv M.

“…Ambulatory monitoring is increasingly important for cardiovascular care but is often limited by the unpredictability of cardiovascular events, the intermittent…”
Get full text

Initial Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion: Shifting Approaches to a Moving Target by Halperin, Jonathan L, Rothman, Kenneth J

Get full text

Machine learning prediction in cardiovascular diseases: a meta-analysis by Krittanawong, Chayakrit, Virk, Hafeez Ul Hassan, Bangalore, Sripal, Wang, Zhen, Johnson, Kipp W., Pinotti, Rachel, Zhang, HongJu, Kaplin, Scott, Narasimhan, Bharat, Kitai, Takeshi, Baber, Usman, Halperin, Jonathan L., Tang, W. H. Wilson

“…Several machine learning (ML) algorithms have been increasingly utilized for cardiovascular disease prediction. We aim to assess and summarize the…”
Get full text

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score by LIP, Gregory Y. H, FRISON, Lars, HALPERIN, Jonathan L, LANE, Deirdre A

“…The purpose of this study was to investigate predictors of bleeding in a cohort of anticoagulated patients and to evaluate the predictive value of several…”
Get full text

The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines by Jacobs, Alice K, Anderson, Jeffrey L, Halperin, Jonathan L

Get full text

Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves by Carnicelli, Anthony P, De Caterina, Raffaele, Halperin, Jonathan L, Renda, Giulia, Ruff, Christian T, Trevisan, Marco, Nordio, Francesco, Mercuri, Michele F, Antman, Elliott, Giugliano, Robert P

Get full text

Preventing Myocardial Infarction in Patients With Atrial Fibrillation: Another Piece of the Puzzle by Halperin, Jonathan L.

“…[Display omitted]…”
Get full text

Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices by Martin, David T, Bersohn, Malcolm M, Waldo, Albert L, Wathen, Mark S, Choucair, Wassim K, Lip, Gregory Y H, Ip, John, Holcomb, Richard, Akar, Joseph G, Halperin, Jonathan L

“…Atrial tachyarrhythmias (ATs) detected by implanted devices are often atrial fibrillation or flutter (AF) associated with stroke. We hypothesized that…”
Get full text

COCATS 4 Introduction by Halperin, Jonathan L., MD, FACC, Williams, Eric S., MD, MACC, Fuster, Valentin, MD, PhD, MACC

“…[...]the curricular milestones underpin the more global ACGME/ABIM reporting milestones (6); the ACC will also provide tools to facilitate mapping of the…”
Get full text

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex by Carnicelli, Anthony P., Hong, Hwanhee, Connolly, Stuart J., Eikelboom, John, Giugliano, Robert P., Morrow, David A., Patel, Manesh R., Wallentin, Lars, Alexander, John H., Cecilia Bahit, M., Benz, Alexander P., Bohula, Erin A., Chao, Tze-Fan, Dyal, Leanne, Ezekowitz, Michael, A.A. Fox, Keith, Gencer, Baris, Halperin, Jonathan L., Hijazi, Ziad, Hohnloser, Stefan H., Hua, Kaiyuan, Hylek, Elaine, Toda Kato, Eri, Kuder, Julia, Lopes, Renato D., Mahaffey, Kenneth W., Oldgren, Jonas, Piccini, Jonathan P., Ruff, Christian T., Steffel, Jan, Wojdyla, Daniel, Granger, Christopher B.

“…Direct oral anticoagulants (DOACs) are preferred over warfarin for stroke prevention in atrial fibrillation. Meta-analyses using individual patient data offer…”
Get full text

Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial by Ezekowitz, Michael D, Pollack, Charles V, Halperin, Jonathan L, England, Richard D, VanPelt Nguyen, Sandra, Spahr, Judith, Sudworth, Maria, Cater, Nilo B, Breazna, Andrei, Oldgren, Jonas, Kirchhof, Paulus

“…Abstract Aim The primary objective was to compare apixaban to heparin/vitamin K antagonist (VKA) in patients with atrial fibrillation (AF) and ≤48 h…”
Get full text